Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cell Biology

Background:

• Human adipose tissue yields adipose tissue-derived stromal cells (ATSCs), which possess renewal capacity and multipotent differentiation potential, similar to bone marrow-derived mesenchymal stem cells (BMSCs).
• Both cell types demonstrate the capacity for ectopic bone formation when supported by suitable scaffolds.

Purpose of the Study:

• To evaluate beta-tricalcium phosphate (beta-TCP) as a scaffold for osteogenic differentiation.
• To compare the osteogenic differentiation potential of ATSCs against BMSCs within the beta-TCP scaffold.

Main Methods:

• ATSCs and BMSCs were cultured on beta-TCP disks within an osteogenic induction medium.
• In vitro osteogenic differentiation was assessed via osteocalcin secretion, scanning electron microscopy, and histology.
• In vivo bone formation was evaluated using ATSC- or BMSC-loaded scaffolds implanted in nude mice.

Main Results:

• Optimal in vitro osteogenic differentiation for ATSCs was achieved when cultured with the beta-TCP disk.
• Histological and SEM analyses confirmed osteogenic potential in both cell types within the beta-TCP scaffold.
• In vivo studies demonstrated comparable bone formation capabilities between ATSCs and BMSCs when utilizing the beta-TCP scaffold.

Conclusions:

• Adipose tissue-derived stromal cells (ATSCs) exhibit a similar capacity for osteogenic differentiation and bone synthesis as bone marrow-derived mesenchymal stem cells (BMSCs) when employed with a beta-TCP scaffold.
• Beta-tricalcium phosphate (beta-TCP) serves as an effective scaffold for promoting osteogenic differentiation of both ATSCs and BMSCs.
• ATSCs represent a viable alternative to BMSCs for bone regenerative applications using beta-TCP scaffolds.